Loading organizations...
§ Venture Capital · Hong Kong, Hong Kong Island, Hong Kong
Investment firm with a focus on the healthcare sector, exploring opportunities in healthcare technology and medical devices.
Healthlink Capital operates as an entity with an undisclosed operational focus and an unconfirmed headquarters location, positioning it within an unspecified market segment. Publicly available information does not detail its specific business model, target customer base, or the services it provides to the market. The organization has not released any public data concerning its financial standing, including funding rounds, assets under management, or its current valuation metrics. Furthermore, details regarding its operational scale, such as employee or user counts, remain unconfirmed in public records. No recognizable names associated with lead investors, significant portfolio companies, or key customers have been publicly identified, leaving its market presence and strategic partnerships unconfirmed. The organization's founding year and the names of its founders are not publicly documented, contributing to a limited public profile for Healthlink Capital.
Healthlink Capital has 1 tracked investment across 1 company. The latest tracked deal is $23.0M Series A in Lyndra Therapeutics in April 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 13, 2017 | Lyndra Therapeutics | $23.0M Series A | Polaris Partners | GF Securities, Mass General Brigham, Quark Venture, Suffolk Equity, Yonghua Capital |